Speaker: Marwan Bukhari
In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19.
In this episode, we discuss JAK inhibitors with Marwan Bukhari, a rheumatologist from the University Hospitals of Morecambe Bay NHS Trust in the UK. He outlines the rationale for investigating these agents, the currently available efficacy data, and the aims of the ongoing TACTIC-R trial.
Listen below or subscribe to this Podcast on:
Google Podcasts | Apple Podcasts | Spotify | Stitcher | TuneIn
About the speaker